HBED: A Potential Alternative to Deferoxamine for Iron-Chelating Therapy
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
To examine the potential clinical usefulness of the hexadentate phenolic aminocarboxylate iron chelatorN,N-bis(2-hydroxybenzyl)ethylenediamine-N,N-diacetic acid (HBED) for the chronic treatment of transfusional iron overload, we compared the iron excretion induced by subcutaneous (SC) injection of HBED and deferoxamine (DFO), the reference chelator, in rodents and primates. In the non–iron-overloaded, bile-duct–cannulated rat, a single SC injection of HBED, 150 μmol/kg, resulted in a net iron excretion that was more than threefold greater than that after the same dose of DFO. In the iron-loaded Cebus apella monkey, a single SC injection of HBED, 150 μmol/kg, produced a net iron excretion that was more than twice that observed after the same dose of SC DFO. In patients with transfusional iron overload, SC injections of HBED may provide a much needed alternative to the use of prolonged parenteral infusions of DFO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site.
Graf, E., Mahoney, J. R., Bryant, R. G., & Eaton, J. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43139-5 · Cited by 855
Cited by
Design of iron chelators with therapeutic application
Liu, Z. D., & Hider, R. C. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00050-4 · Cited by 287
Design of clinically useful iron(III)‐selective chelators
Liu, Z. D., & Hider, R. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1027 · Cited by 266
Design of iron chelators with therapeutic application
Zhou, T., Ma, Y., Kong, X., & Hider, R. C. (2012) · Dalton Transactions · doi:10.1039/c2dt12159j · Cited by 136
Iron chelators and iron toxicity
Brittenham, G. M. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00101-0 · Cited by 54
“HBED was reexamined as a parenteral chelator after results of studies in iron-loaded primates revealed a level of iron excretion more than twice that produced by an equimolar dose of deferoxamine (Bergeron et al., 1998; 1999a, 2002).”
ResultSelf-citationDuenas-Ramirez, P., Bertagnolli, C., Müller, R., Sartori, K., Boos, A., Elhabiri, M., Bégin-Colin, S., & Mertz, D. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.06.013 · Cited by 34
Metadata
- Authors
- Bergeron, R. J., Wiegand, J., & Brittenham, G. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1998-02-15
- Volume
- 91
- Issue
- 4
- Pages
- 1446-1452
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W26210460
- Cited by
- 66
- References
- 1
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HBED: A Potential Alternative to Deferoxamine for Iron-Chelating Therapy. https://app.cochat.ai/papers/10.1182/blood.v91.4.1446
- The paper
- Bergeron, R. J., Wiegand, J., & Brittenham, G. M. (1998). HBED: A Potential Alternative to Deferoxamine for Iron-Chelating Therapy. Blood. https://doi.org/10.1182/blood.v91.4.1446
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.